LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Researchers Reveal a Microchip Magnetic Cell Sorting Device

By LabMedica International staff writers
Posted on 07 Mar 2016
Image: Progressively spaced micropillars highlight the new magnetic ratcheting cell sorting system (Photo courtesy of University of California, Los Angeles).
Image: Progressively spaced micropillars highlight the new magnetic ratcheting cell sorting system (Photo courtesy of University of California, Los Angeles).
A novel magnetic cell sorting system may potentially be reduced in size for development into a "lab-on-a-chip" device.

The system, which was invented by investigators at the University of California, Los Angeles (USA), comprised a microchip coated with an array of microscale pillars set progressively farther apart, and a spinning magnet that pulled magnetically labeled cells over the pillars. The system separated and concentrated magnetic beads based on iron oxide content (IOC) and cells based on surface expression. Particles with higher IOC separated and equilibrated along the miropillar array at larger pitches.

The investigators described using the method in the February 17, 2016, online edition of the journal Small. They reported that LNCaP cells were separated based on the bound quantity of one-micrometer anti-epithelial cell adhesion molecule (EpCAM) particles as a metric for expression. The ratcheting cytometry system was able to resolve a differential of 13 bound particles, successfully distinguishing LNCaP from PC3 populations based on EpCAM expression. This result matched that obtained with fluorescence-based flow cytometry analysis. As a proof-of-concept, EpCAM-labeled cells from patient blood were isolated with 74% purity, demonstrating the device's potential as a quantitative magnetic separation instrument.

“What we think is only one cell type is often a heterogeneous mixture, and without technologies to separate quantitatively, these nuanced differences get lost,” said senior author Dr. Dino Di Carlo, professor of bioengineering at the University of California, Los Angeles. “For example, therapeutically active progenitor cells may look very similar to the other contaminating cells that provide no therapeutic benefit.”

Related Links:

University of California, Los Angeles


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Clinical Chemistry System
P780

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more